◆英語タイトル：Alder Biopharmaceuticals Inc (ALDR) - Financial and Strategic SWOT Analysis Review
◆レポート形式：英語 / PDF
Alder Biopharmaceuticals Inc (Alder) develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases. The company offers technologies such as the antibody selection (ABS) system and novel Mab Xpress antibody production system. Its pipeline products include ALD403, ALD1613 and Clazakizumab Alder’s ALD403 is our transformative monoclonal antibody targeted to calcitonin gene-related peptide, or CGRP, for migraine prevention. Its Clazakizumab is a novel monoclonal antibody used for the treatment of rheumatoid arthritis and psoriatic arthritis. The company’s clinical trial products include ALD403-CLIN-006 and ALD403-CLIN-005. Alder is headquartered in Bothell, Washington, the US.
Alder Biopharmaceuticals Inc Key Recent Developments
Oct 27, 2016: Alder BioPharmaceuticals Announces Third Quarter 2016 Financial and Operating Results
Oct 11, 2016: Alder BioPharmaceuticals Promotes Larry Benedict to Executive Vice President of Finance and Principal Accounting Officer
Sep 21, 2016: Alder BioPharmaceuticals Appoints Nancy L. Boman, M.D., Ph.D., Senior Vice President of Regulatory Affairs and Pharmacovigilance
Jul 26, 2016: Alder BioPharmaceuticals Reports Second Quarter 2016 Financial and Operating Results
Jun 29, 2016: Alder BioPharmaceuticals Appoints Timothy M. Whitaker, M.D., Chief Medical Officer
This comprehensive SWOT profile of Alder Biopharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Alder Biopharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Alder Biopharmaceuticals Inc – Key Information
Alder Biopharmaceuticals Inc – Overview
Alder Biopharmaceuticals Inc – Key Employees
Alder Biopharmaceuticals Inc – Key Employee Biographies
Alder Biopharmaceuticals Inc – Key Operational Heads
Alder Biopharmaceuticals Inc – Major Products and Services
Alder Biopharmaceuticals Inc – History
Alder Biopharmaceuticals Inc – Company Statement
Alder Biopharmaceuticals Inc – Locations And Subsidiaries
Alder Biopharmaceuticals Inc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Alder Biopharmaceuticals Inc – Business Description
Alder Biopharmaceuticals Inc – Corporate Strategy
Alder Biopharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Alder Biopharmaceuticals Inc – Strengths
Alder Biopharmaceuticals Inc – Weaknesses
Alder Biopharmaceuticals Inc – Opportunities
Alder Biopharmaceuticals Inc – Threats
Alder Biopharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Alder Biopharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Alder Biopharmaceuticals Inc, Key Information
Alder Biopharmaceuticals Inc, Key Ratios
Alder Biopharmaceuticals Inc, Share Data
Alder Biopharmaceuticals Inc, Major Products and Services
Alder Biopharmaceuticals Inc, History
Alder Biopharmaceuticals Inc, Key Employees
Alder Biopharmaceuticals Inc, Key Employee Biographies
Alder Biopharmaceuticals Inc, Key Operational Heads
Alder Biopharmaceuticals Inc, Other Locations
Alder Biopharmaceuticals Inc, Subsidiaries
Alder Biopharmaceuticals Inc, Key Manufacturing facilities
Alder Biopharmaceuticals Inc, Key Competitors
Alder Biopharmaceuticals Inc, SWOT Analysis
Alder Biopharmaceuticals Inc, Ratios based on current share price
Alder Biopharmaceuticals Inc, Annual Ratios
Alder Biopharmaceuticals Inc, Interim Ratios
Capital Market Ratios
List of Figures
Alder Biopharmaceuticals Inc, Performance Chart
Alder Biopharmaceuticals Inc, Ratio Charts
Alder Biopharmaceuticals Inc (ALDR)：企業財務及び戦略的SWOT分析(Alder Biopharmaceuticals Inc (ALDR) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。